Guild admits it was ‘blindsided’ by PSA signatory announcement

It was also ‘perplexed’ about the Health Minister’s decision to announce dual listing of medicines without consultation There has been a concerning lack of consultation regarding significant decisions that have been made by the Health Minister in recent months, said Guild executive director Pam Price at the PharmaDispatch 2019 conference in Sydney on Monday. The